文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

早产儿低风险不发生早产儿视网膜病变的相关因素

Factors in Premature Infants Associated With Low Risk of Developing Retinopathy of Prematurity.
PubMed 文献 · JAMA Ophthalmol · 2019-01-01

该研究基于e-ROP研究数据,分析1257例出生体重<1251g早产儿,发现27–33周龄组出院时59%无ROP,而<27周组仅15%无ROP;37周龄时无ROP且随访>85%的婴儿中无人接受治疗。结论提示≥27周且出生体重>750g的婴儿若近足月时仍未检出ROP,进一步筛查价值有限。

要点

  • 27–33周组出院时无ROP比例59%,显著高于<27周组的15%(差44%,95%CI 38.5%-48.1%,P≤.001)。
  • 37周龄时无ROP且随访>85%的婴儿中无人因ROP接受治疗(95%CI 0%-0.98%)。
  • 27–33周组多因素分析中,较大出生体重(OR 4.1,95%CI 1.6-10.3)和较高胎龄(OR 4.0,95%CI 1.5-10.8)与无ROP显著相关。

核心结论

  • 对于胎龄≥27周且出生体重>750g的婴儿,若近足月时出院前未检出ROP,进一步ROP监测价值有限。

研究设计与样本

  • 基于e-ROP研究的前瞻性院内ROP检查结果进行事后分析,纳入出生体重<1251g的早产儿1257例。

主要发现

  • 共完成4113次ROP检查,1153次(38%)未见ROP,456例(36%)在研究中心出院或研究终点前无ROP。
  • 在32周和33周检查无ROP的婴儿中,分别有16例(9.4%)和14例(5.3%)后续接受ROP治疗。
  • 出院时27–33周组无ROP比例为59%,<27周组为15%(差44%,95%CI 38.5%-48.1%,P≤.001)。
  • 37周龄时无ROP且随访>85%的婴儿中无人接受ROP治疗(95%CI 0%-0.98%)。
  • 27–33周组多因素分析显示,较大出生体重(OR 4.1,95%CI 1.6-10.3)和较高胎龄(OR 4.0,95%CI 1.5-10.8)与无ROP显著相关。

关键数值与推荐

  • 27–33周组出院时无ROP比例为59%,<27周组为15%。
  • 32周和33周检查无ROP的婴儿后续治疗比例分别为9.4%和5.3%。
  • 37周龄无ROP且随访>85%的婴儿治疗比例为0%(95%CI 0%-0.98%)。
  • 较大出生体重OR 4.1(95%CI 1.6-10.3),较高胎龄OR 4.0(95%CI 1.5-10.8)。

临床怎么用

  • 对胎龄≥27周且出生体重>750g的早产儿,若近足月出院前未检出ROP,可考虑终止 further ROP监测。
  • 需开展全部风险婴儿的研究以制定更特异、客观的ROP监测终止标准,并将资源集中于高风险婴儿。

局限性

  • 本研究为事后分析,结论需在前瞻性研究中验证。
  • 研究仅纳入出生体重<1251g的婴儿,未覆盖所有出生体重范围。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Most premature infants will not develop retinopathy of prematurity (ROP) of clinical relevance, yet screening evaluations often continue beyond hospital discharge, even for those infants without ROP. OBJECTIVES: To identify the characteristics of infants at low risk for ROP, for whom further postdischarge screening may be of limited value. DESIGN, SETTING, AND PARTICIPANTS: This study took place in North American neonatal intensive care units where clinicians had expertise in ROP. Infants with birth weight less than 1251 g who were born at or transferred into an Telemedicine Approaches to Evaluating Acute-Phase ROP (e-ROP) study center were enrolled. The study included post hoc analysis of prospectively collected in-hospital ROP examination results among infants enrolled in the e-ROP study. We characterized infants without ROP and performed logistic regression on the subset of infants who were 27 to 33 weeks' gestational age to determine characteristics associated with the absence of ROP during all in-hospital examinations. MAIN OUTCOMES AND MEASURES: The main measure was the absence of ROP prior to hospital discharge; the main outcome was treatment for ROP. RESULTS: A total of 1257 infants born at 22 to 35 weeks' gestation (median [interquartile range (IQR)], 26 [25-28] weeks) with birth weights less than 1251 g (median [IQR], 860 [690-1040] g) underwent 4113 ROP examinations between 31 and 47 weeks' postmenstrual age. Overall, 1153 examinations (38%) showed no ROP, and 456 infants (36%) did not have ROP prior to study center discharge or study end point. Among infants without ROP during examinations at 32 and 33 weeks' postmenstrual age, 16 (9.4%) and 14 (5.3%) subsequently underwent ROP treatment, respectively. At hospital discharge, there was no ROP in 59% of infants of 27 to 33 weeks' gestational age, compared with 15% of those who were less than 27 weeks' gestational age (difference, 44% [95% CI, 38.5%-48.1%]; P ≤ .001). With more than 85% follow-up among infants without ROP by 37 weeks' postmenstrual age, none (95% CI, 0%-0.98%) were treated for ROP. In multivariate analysis of infants born at 27 to 33 weeks' gestation, larger birth weight (OR, 4.1 [95% CI, 1.6-10.3]) and higher gestational age (OR, 4.0 [95% CI, 1.5-10.8]) were significantly associated with absence of ROP. CONCLUSIONS AND RELEVANCE: These findings suggest that, for infants of 27 weeks' gestational age or greater and birth weights larger than 750 g, if no ROP has been detected by discharge at near-term postmenstrual age, then further ROP surveillance has limited value. Studies of all infants at risk are needed to develop more specific, objective criteria for termination of ROP surveillance and focus resources on infants at higher risk of ROP. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01264276.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Wade KC, Ying GS, Baumritter A, et al. Factors in Premature Infants Associated With Low Risk of Developing Retinopathy of Prematurity. JAMA Ophthalmol. 2019. PMID: 30452500. doi:10.1001/jamaophthalmol.2018.5520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。